{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:41:02Z","timestamp":1777887662157,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011096","name":"Philippine Council for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijid.2026.108461","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:36:36Z","timestamp":1770222996000},"page":"108461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative evaluation of SARS-CoV-2 antigens as capture and detection elements in an in-house antigen-based ELISA for COVID-19 total antibody detection"],"prefix":"10.1016","volume":"165","author":[{"given":"Catherine B.","family":"Masangkay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4198-4398","authenticated-orcid":false,"given":"Jhunel G.","family":"Vinarao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Fedelino F.","family":"Malbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria June D.","family":"Qui\u00f1ones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Sarah L.","family":"Lenon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erryl Kate","family":"Noveno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prince Andre","family":"Diagmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Babad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Glazel","family":"Noro\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalino","family":"Demetria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Normando","family":"Gonzaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Faustino C.","family":"Icatlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijid.2026.108461_bib0001","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s44229-022-00014-x","article-title":"Immunoglobulin rapid test sensitivity in pcr-positive Covid-19 patients","volume":"4","author":"Alharbi","year":"2022","journal-title":"Dr. Sulaiman Al Habib Med J"},{"key":"10.1016\/j.ijid.2026.108461_bib0002","article-title":"Evaluation of serological tests for sars-cov-2: implications for serology testing in a low-prevalence setting","author":"Bond","year":"2020","journal-title":"medRxiv"},{"issue":"2","key":"10.1016\/j.ijid.2026.108461_bib0003","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00763-2020","article-title":"Serology characteristics of SARS-CoV-2 infection since exposure and post-symptom onset","volume":"56","author":"Lou","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ijid.2026.108461_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-020-00199-1","article-title":"Immunization with the receptor-binding domain of sars-cov-2 elicits antibodies cross-neutralizing sars-cov-2 and sars-cov without antibody-dependent enhancement","volume":"6","author":"Zang","year":"2020","journal-title":"Cell Discov"},{"issue":"2","key":"10.1016\/j.ijid.2026.108461_bib0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cid\/ciaa979","article-title":"Magnitude and kinetics of anti\u2013severe acute respiratory syndrome coronavirus 2 antibody responses and their relationship to disease severity","volume":"72","author":"Lynch","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"31","key":"10.1016\/j.ijid.2026.108461_bib0006","doi-asserted-by":"crossref","first-page":"E1030","DOI":"10.1503\/cmaj.230249","article-title":"The evolution of sars-cov-2 seroprevalence in Canada: a time-series study, 2020\u20132023","volume":"195","author":"Murphy","year":"2023","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.ijid.2026.108461_bib0007","article-title":"Omicron b.1.1.529 variant infections associated with severe disease are uncommon in a covid-19 under-vaccinated, high sars-cov-2 seroprevalence population in Malawi","author":"Mseka","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.ijid.2026.108461_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2020.115140","article-title":"Monitoring antibody response following sars-cov-2 infection: diagnostic efficiency of 4 automated immunoassays","volume":"98","author":"Wolff","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2026.108461_bib0009","article-title":"Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated covid-19 vaccine","volume":"13","author":"Chen","year":"2025","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijid.2026.108461_bib0010","article-title":"Safety and immunogenicity of a booster sars-cov-2 vaccination in patients with chronic liver disease","author":"Li","year":"2022","journal-title":"medRxiv"},{"issue":"16","key":"10.1016\/j.ijid.2026.108461_bib0011","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the omicron (b.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108461_bib0012","article-title":"The serological diversity of serum IgG\/IgA\/IgM against the SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan","author":"Kaneko","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.ijid.2026.108461_bib0013","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cca.2020.04.026","article-title":"IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: a longitudinal study","volume":"507","author":"Padoan","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"48","key":"10.1016\/j.ijid.2026.108461_bib0014","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ijid.2026.108461_bib0015","series-title":"The Proteomics Protocols Handbook","first-page":"571","article-title":"Protein identification and analysis tools on the Expasy server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.ijid.2026.108461_bib0016","series-title":"Pacific Symposium on Biocomputing","first-page":"310","article-title":"Prediction of glycosylation across the human proteome and the correlation to protein function","author":"Gupta","year":"2002"},{"issue":"6","key":"10.1016\/j.ijid.2026.108461_bib0017","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/jpm11060576","article-title":"Antibody response following a two-dose mRNA vaccination regimen, in health care workers of a tertiary hospital in Athens, Greece","volume":"11","author":"Kontou","year":"2021","journal-title":"J Pers Med"},{"issue":"1","key":"10.1016\/j.ijid.2026.108461_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28527-x","article-title":"Population antibody responses following COVID-19 vaccination in 212,102 individuals","volume":"13","author":"Ward","year":"2022","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ijid.2026.108461_bib0019","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001721","article-title":"Evaluation and validation of a commercial ELISA versus the in vitro toxin neutralization assay for determination of diphtheria anti-toxin in human serum","volume":"72","author":"Kitamura","year":"2023","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.ijid.2026.108461_bib0020","doi-asserted-by":"crossref","DOI":"10.4102\/ajlm.v13i1.2373","article-title":"Diagnostic cut-off value of haemoglobin A1c for diabetes mellitus in Harare, Zimbabwe","volume":"13","author":"Bvumbi","year":"2024","journal-title":"Afr J Lab Med"},{"key":"10.1016\/j.ijid.2026.108461_bib0021","article-title":"IgG antibodies against SARS-CoV-2 correlate with days from symptom onset, viral load and IL-10","author":"Young","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ijid.2026.108461_bib0022","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"issue":"32","key":"10.1016\/j.ijid.2026.108461_bib0023","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","article-title":"Evidence for antibody as a protective correlate for COVID-19 vaccines","volume":"39","author":"Earle","year":"2021","journal-title":"Vaccine"},{"issue":"6576","key":"10.1016\/j.ijid.2026.108461_bib0024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:20:20Z","timestamp":1777609220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":24,"alternative-id":["S1201971226000962"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108461","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative evaluation of SARS-CoV-2 antigens as capture and detection elements in an in-house antigen-based ELISA for COVID-19 total antibody detection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108461"}}